The FDA has accepted Regeneron Pharmaceuticals’ sBLA for Eylea HD (aflibercept) injection 8mg for priority review.

The veteran all-star Milwaukee Bucks guard was diagnosed with deep vein thrombosis (a blood clot in his lower right leg). He will be out of action for a significant period of time. Here's some ...

Vision Australia is well on the way to reaching its annual target in the 100K Your Way fundraising challenge. For a second year, Vision Australia Radio ...

BRIDGEWATER, N.J. and BENGALURU, Karnataka, India, April 15, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon ...

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced today a settlement and license agreement with ...

High cholesterol is a common health condition that doesn't usually produce any noticeable symptoms, but there are some ...

A new study found that an artificial intelligence reading label system improves ophthalmologists' diagnostic accuracy for retinal diseases and could be valuable in future medical education. A new ...

Bayer has submitted an application to the European Medicines Agency (EMA) seeking approval of aflibercept 8 mg (114.3 mg/ml solution for injection) for the treatment of patients with macular edema ...

It's officially pickleball season at Central Park in New York City ... people visited the courts over the past two years. You can sign up for a court and learn more about the summer programming ...

Senior Alex Solorio signed to continue his academic and wrestling career at North Central College in Naperville, Illinois. The senior had a busy season, juggling daily classes and wrestling meets ...

31,181 people played the daily Crossword recently. Can you solve it faster than others?31,181 people played the daily Crossword recently. Can you solve it faster than others?

for the treatment of patients with macular edema following retinal vein occlusion (RVO) including central, branch and hemiretinal vein occlusion. This would be the third indication for aflibercept 8 ...